AndroGel (Testosterone Gel): Benefits, Risks, and What to Know

AndroGel (and its sibling Testogel) is a transdermal testosterone gel approved by the FDA in February 2000 for men with hypogonadism. The short version: it restores testosterone in men who genuinely don’t make enough, and it does so with a smoother serum profile than injections. The catch is secondary transfer. Testosterone left on the skin can be passed to a partner or child through ordinary contact, and the FDA has boxed that warning. That single risk is the most important thing to understand about gel TRT.

What AndroGel is and what it treats

AndroGel is a hydroalcoholic gel carrying about 1% testosterone by weight. Llewellyn’s Anabolics (11th ed., p.214) describes it as having roughly 10% transdermal bioavailability, meaning a standard 5-gram dose delivers about 5 mg of hormone systemically. The dataset pegs the apparent terminal half-life near 72 hours, reflecting the skin reservoir rather than clearance of the hormone itself, with peak serum around 10 hours after application.

Clinically it’s indicated for adult men with conditions tied to a deficiency or absence of endogenous testosterone. That covers primary hypogonadism (Klinefelter’s, orchitis, orchiectomy, chemotherapy damage) and hypogonadotropic hypogonadism (pituitary or hypothalamic causes). Diagnosis requires two low morning testosterone draws plus symptoms, not just a single borderline number.

The textbook reports an 87% clinical success rate, largely because a daily gel is easier to stick with than deep intramuscular injections. Steady daily application builds a stable serum profile without the sharp peaks and troughs of injectable esters, which is why some men tolerate it better in terms of mood and hematocrit swing.

AndroGel benefits for men: what the evidence actually supports

For men with confirmed low testosterone, the benefits are real and well-documented. Restoring serum testosterone into the eugonadal range (roughly 300 to 1000 ng/dL) improves the symptoms that define hypogonadism:

• Low libido and erectile dysfunction
• Persistent fatigue and depressed mood
• Loss of muscle mass and strength gains
• Increased body fat, particularly visceral

These benefits only hold when the diagnosis is genuine. A 2015 pharmacokinetic paper in Sexual Medicine (Kaminetsky et al., SM2-3-269) treated men with baseline total testosterone near 200 ng/dL and restored them to a mean steady-state of 422 ng/dL on 50 mg subcutaneous testosterone enanthate weekly, which is the same principle gel TRT follows. Restoring a deficient man helps. Giving testosterone to a man who’s already in range doesn’t produce “more benefits,” and it does suppress the HPTA axis.

One genuine PK advantage of the gel route: less estradiol and hematocrit swing than large-bore intramuscular injections, because there’s no supraphysiological peak to aromatize from. The trade-off is daily adherence and the transfer problem.

AndroGel benefits for women: the honest answer

AndroGel isn’t FDA-approved for women. That’s the starting point.

Testosterone gel is sometimes used off-label in women for hypoactive sexual desire disorder (HSDD), particularly in postmenopausal women who’ve been appropriately worked up and have no other reversible cause. The doses are tiny, roughly a tenth or less of the male dose, and are typically compounded or measured as micro-doses from a male pump. Evidence here is mixed and the debate is live. Global consensus statements on female testosterone therapy have repeatedly stressed that treatment should be reserved for HSDD that hasn’t responded to other approaches, that it should use the lowest effective dose, and that it isn’t a general “wellness” or anti-aging intervention.

So if you searched “androgel benefits for women,” the honest answer is: any benefit is limited to a narrow, off-label, low-dose context for a specific diagnosed condition. There’s no approved female use, and the evidence base for long-term safety in women is thinner than for men. Anyone considering this needs an endocrinologist or sexual-medicine specialist, not a self-prescribed pump.

AndroGel side effects for women: secondary transfer is the core risk

This is the section that matters most for the keyword cluster. “Side effects for women” splits into two very different scenarios.

1. Secondary transfer from a male user

This is the dominant risk, and it’s the reason for the FDA black-box warning. A woman in close skin contact with a man who’s recently applied gel can absorb meaningful testosterone. Llewellyn’s Anabolics cites AndroGel-specific data showing that female partners of male patients saw their serum testosterone roughly double after just 15 minutes of rigorous skin-on-skin contact, when that contact happened 2 to 12 hours after application. The same source notes that transfer was completely avoided when the male wore a shirt.

The 2015 Sexual Medicine paper (SM2-3-269) names the same hazard explicitly, noting that the risk of “passive transference to women and children associated with topical gels” is one of the reasons alternative delivery systems get developed, and references de Ronde’s published case report on hyperandrogenism after gel transfer. The harm reduction list:

• Apply to dry, intact skin on shoulders, upper arms, or abdomen (not genitals)
• Wash hands with soap and water immediately after
• Cover the site with clothing once the gel has dried
• Do not shower or swim for the label-specified window after application
• Keep women and children away from unwashed application sites and from towels, bedding, or clothing that contacted the gel

Signs of unintended exposure in a female partner or child: acne, deepening voice, increased facial or body hair, menstrual irregularity, and in children, early pubic hair or genital changes. Any of these warrant stopping the gel and seeing a clinician.

2. Direct virilization if a woman uses it

When women take testosterone directly, even at low doses, the androgenic side effects are the classic virilizing set: hirsutism, voice deepening (often irreversible), clitoral enlargement, acne, and menstrual disruption. Llewellyn’s Anabolics warns that testosterone is a strong androgen and that women are at particular risk for these effects, which is why the textbook doesn’t recommend it for physique or performance use in women.

DHT elevation: why gel hits the scalp and prostate harder

Transdermal testosterone converts to dihydrotestosterone (DHT) more readily than injectable forms. The reason is skin: the 5-alpha reductase enzyme that converts testosterone to DHT is concentrated in skin and scalp tissue, and gel delivers the hormone right into that tissue.

What this means in practice. Users prone to androgenetic alopecia may notice faster hair loss on gel than on injectable testosterone at comparable serum levels. Prostate-specific antigen (PSA) monitoring matters because DHT is the main androgen driving prostate tissue. A 5-alpha reductase inhibitor (finasteride, dutasteride) can blunt the skin-and-scalp conversion, but it doesn’t cleanly separate anabolic from androgenic effects, and adding one is a separate medical decision with its own profile.

How AndroGel fits into TRT planning

For a man with confirmed hypogonadism, gel is a legitimate first-line option alongside injectable esters and other delivery routes. The choice usually comes down to preference, needle tolerance, and whether the daily routine and the transfer precautions are manageable. If there’s a female partner, a child, or regular close contact with others, the transfer risk has to drive the decision, not the convenience.

For anyone considering gel outside a diagnosed deficiency, the framework is the same as any testosterone product: get the bloodwork, confirm the diagnosis, and work with a clinician. Testosterone isn’t a supplement, and restoring a normal level in a deficient man is very different from chasing a supra-normal level in someone who’s already in range.

FAQ

Does AndroGel work for low testosterone in men?

Yes, when the deficiency is genuine. Restoring serum testosterone to the eugonadal range improves libido, mood, energy, and body composition in men with confirmed hypogonadism. It doesn’t benefit men who are already in the normal range.

Can women use AndroGel safely?

Not as an approved product. Off-label, very low-dose testosterone is sometimes used for HSDD in postmenopausal women under specialist supervision, but AndroGel itself isn’t approved for women and the male doses carry real virilization risk.

How does testosterone transfer from a male user to a partner?

Through skin-to-skin contact with the application site, or contact with unwashed clothing, towels, or bedding. The AndroGel data cited in Llewellyn’s Anabolics shows female partner serum testosterone roughly doubled after 15 minutes of skin contact. Covering the site and washing hands prevents most transfer.

Does AndroGel raise DHT more than injections?

Yes. Skin is rich in 5-alpha reductase, and transdermal delivery exposes skin and scalp tissue directly. This is why gel users may see more hair-loss acceleration and why PSA monitoring matters. A 5-alpha reductase inhibitor can blunt this, under medical guidance.

What are the first signs of unintended testosterone exposure in a woman or child?

Acne, increased facial or body hair, voice changes, and menstrual irregularity in women. In children, look for early pubic hair or genital changes. If any appear, stop the gel and seek medical evaluation.

Sources

• Llewellyn W. Anabolics (11th ed.), AndroGel entry, p.214. Covers approval history, 10% bioavailability, 87% clinical success, and the female-partner transfer data.
• Kaminetsky J, Jaffe JS, Swerdloff RS. Pharmacokinetic profile of subcutaneous testosterone enanthate delivered via a novel, prefilled single-use autoinjector: A phase II study. Sexual Medicine 2015;3:269-279 (SM2-3-269). Cites the gel secondary-transfer warning and the de Ronde 2009 case report.
• de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies. Human Reproduction 2009;24:425-428.